What does CUSIP 92790C104 represent in this 13F holders report?

CUSIP 92790C104 is the security identifier for VRDN - Viridian Therapeutics, Inc.\DE - Common Stock used to aggregate holder disclosures.

How many institutions held VRDN - Viridian Therapeutics, Inc.\DE - Common Stock in Q3 2022?

104 institutional investors reported VRDN - Viridian Therapeutics, Inc.\DE - Common Stock for Q3 2022. Use the holders table for investor-level position and value details.

Viridian Therapeutics, Inc.\DE - Common Stock (VRDN)

CUSIP: 92790C104

Q3 2022 13F Holders as of 30 Sep 2022

Type / Class: Equity / Common Stock
Shares outstanding: 101,911,273
Total 13F shares: 37,976,766
Share change: +9,583,568
Total reported value: $778,702,810
Put/Call ratio: 26%
Price per share: $20.51
Number of holders: 104
Value change: +$213,427,951
Number of buys: 80
Number of sells: 24

Quarterly Holders Quick Answers

What is CUSIP 92790C104?
CUSIP 92790C104 identifies VRDN - Viridian Therapeutics, Inc.\DE - Common Stock in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Next holder-history checks

These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.

Back to full security ownership history for the broader multi-quarter picture.
Latest 13F filings for newly reported positions across managers.
Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
SEC investors directory for manager drilldown.

Explore More Reporting Periods

Jump to adjacent filing periods for faster comparison and easier crawl discovery.

Newer quarter: Q4 2022
Previous quarter: Q2 2022

Recent filing periods for CUSIP 92790C104:

Q1 2026 Q4 2025 Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024

Top shareholders of VRDN - Viridian Therapeutics, Inc.\DE - Common Stock (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

Holder	Source	Role / Reporting	Ownership %	Shares	Holdings Value	12M Net Δ	As of	Details
Frazier Life Sciences Public Fund, L.P.	3/4/5	10%+ Owner	— class O/S missing	1,505,200	$31,609,200	—	23 Sep 2021	3/4/5
VR Adviser, LLC	13F	Company	1.8%	1,852,919	$21,438,000	—	30 Jun 2022	13F
BVF INC/IL	13F	Company	1.7%	1,744,012	$20,178,000	—	30 Jun 2022	13F
Commodore Capital LP	13F	Company	1.6%	1,638,609	$18,959,000	—	30 Jun 2022	13F
BlackRock Finance, Inc.	13F	Company	1.4%	1,422,824	$16,462,000	—	30 Jun 2022	13F
VANGUARD GROUP INC	13F	Company	1.4%	1,410,902	$16,324,000	—	30 Jun 2022	13F
TCG Crossover Management, LLC	13F	Company	1.3%	1,314,000	$15,203,000	—	30 Jun 2022	13F
Paradigm Biocapital Advisors LP	13F	Company	1.3%	1,306,569	$15,117,000	—	30 Jun 2022	13F
Vivo Capital, LLC	13F	Company	1.3%	1,300,000	$15,041,000	—	30 Jun 2022	13F
Deep Track Capital, LP	13F	Company	1.1%	1,170,290	$13,540,000	—	30 Jun 2022	13F
MILLENNIUM MANAGEMENT LLC	13F	Company	1.1%	1,126,085	$13,029,000	—	30 Jun 2022	13F
Frazier Life Sciences Management, L.P.	13F	Company	0.96%	980,302	$11,342,000	—	30 Jun 2022	13F
PERCEPTIVE ADVISORS LLC	13F	Company	0.95%	971,832	$11,244,000	—	30 Jun 2022	13F
Fairmount Funds Management LLC	13F	Company	0.93%	944,092	$10,923,000	—	30 Jun 2022	13F
CITADEL ADVISORS LLC	13F	Company	0.91%	932,299	$10,786,000	—	30 Jun 2022	13F
Cormorant Asset Management, LP	13F	Company	0.86%	877,500	$10,153,000	—	30 Jun 2022	13F
Soleus Capital Management, L.P.	13F	Company	0.83%	841,018	$9,731,000	—	30 Jun 2022	13F
Point72 Asset Management, L.P.	13F	Company	0.78%	790,400	$9,145,000	—	30 Jun 2022	13F
D. E. Shaw & Co., Inc.	13F	Company	0.74%	759,128	$8,783,000	—	30 Jun 2022	13F
Ghost Tree Capital, LLC	13F	Company	0.59%	600,000	$6,942,000	—	30 Jun 2022	13F
Kynam Capital Management, LP	13F	Company	0.58%	590,143	$6,828,000	—	30 Jun 2022	13F
Woodline Partners LP	13F	Company	0.54%	552,371	$6,391,000	—	30 Jun 2022	13F
Ally Bridge Group (NY) LLC	13F	Company	0.49%	496,012	$5,739,000	—	30 Jun 2022	13F
STATE STREET CORP	13F	Company	0.45%	455,065	$5,265,000	—	30 Jun 2022	13F
GEODE CAPITAL MANAGEMENT, LLC	13F	Company	0.44%	449,660	$5,202,000	—	30 Jun 2022	13F
Eversept Partners, LP	13F	Company	0.44%	445,592	$5,155,499	—	30 Jun 2022	13F
MARSHALL WACE, LLP	13F	Company	0.44%	444,799	$5,145,000	—	30 Jun 2022	13F
TANG CAPITAL MANAGEMENT LLC	13F	Company	0.39%	400,000	$4,628,000	—	30 Jun 2022	13F
FRANKLIN RESOURCES INC	13F	Company	0.25%	250,000	$2,893,000	—	30 Jun 2022	13F
NORTHERN TRUST CORP	13F	Company	0.24%	243,956	$2,823,000	—	30 Jun 2022	13F
ACUTA CAPITAL PARTNERS, LLC	13F	Company	0.23%	234,026	$2,708,000	—	30 Jun 2022	13F
Atlas Venture Advisors, Inc.	13F	Company	0.21%	209,505	$2,424,000	—	30 Jun 2022	13F
Walleye Capital LLC	13F	Company	0.18%	178,451	$2,065,000	—	30 Jun 2022	13F
PURA VIDA INVESTMENTS, LLC	13F	Company	0.1%	105,460	$1,220,000	—	30 Jun 2022	13F
Atlas Venture Life Science Advisors, LLC	13F	Company	0.09%	90,072	$1,042,000	—	30 Jun 2022	13F
SUSQUEHANNA INTERNATIONAL GROUP, LLP	13F	Company	0.09%	87,254	$1,010,000	—	30 Jun 2022	13F
LMR Partners LLP	13F	Company	0.08%	80,397	$930,000	—	30 Jun 2022	13F
Bank of New York Mellon Corp	13F	Company	0.07%	69,280	$802,000	—	30 Jun 2022	13F
CHARLES SCHWAB INVESTMENT MANAGEMENT INC	13F	Company	0.07%	68,246	$790,000	—	30 Jun 2022	13F
BRIDGER MANAGEMENT, LLC	13F	Company	0.07%	66,300	$767,000	—	30 Jun 2022	13F
DRIEHAUS CAPITAL MANAGEMENT LLC	13F	Company	0.06%	66,073	$764,000	—	30 Jun 2022	13F
Polar Asset Management Partners Inc.	13F	Company	0.06%	59,700	$691,000	—	30 Jun 2022	13F
Nuveen Asset Management, LLC	13F	Company	0.06%	58,915	$681,000	—	30 Jun 2022	13F
ALLIANCEBERNSTEIN L.P.	13F	Company	0.05%	50,479	$584,000	—	30 Jun 2022	13F
Bellevue Group AG	13F	Company	0.05%	49,000	$567,000	—	30 Jun 2022	13F
HighVista Strategies LLC	13F	Company	0.04%	45,039	$521,000	—	30 Jun 2022	13F
Swiss National Bank	13F	Company	0.04%	36,700	$425,000	—	30 Jun 2022	13F
OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC)	13F	Company	0.03%	34,389	$398,000	—	30 Jun 2022	13F
RHUMBLINE ADVISERS	13F	Company	0.03%	31,713	$367,000	—	30 Jun 2022	13F
MORGAN STANLEY	13F	Company	0.03%	27,583	$319,000	—	30 Jun 2022	13F

Institutional Holders of Viridian Therapeutics, Inc.\DE - Common Stock (VRDN) as of Q3 2022

As of 30 Sep 2022, Viridian Therapeutics, Inc.\DE - Common Stock (VRDN) was held by 104 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 37,976,766 shares. The largest 10 holders included COMMODORE CAPITAL LP, VR Adviser, LLC, BlackRock Inc., Deep Track Capital, LP, VANGUARD GROUP INC, BVF INC/IL, Vivo Capital, LLC, Paradigm Biocapital Advisors LP, Fairmount Funds Management LLC, and CITADEL ADVISORS LLC. This page lists 104 institutional shareholders reporting positions in this security for the Q3 2022 filing period.

Investor	Option	Weight %	Change %	Value $	* Price	Shares	Share Change	Activity	Report Period

Compare Q3 2022 vs Q2 2022 Across Filers

Q2 2022 holders

Q3 2022 holders

104

Holder diff

Investor	Q2 2022 Shares	Q3 2022 Shares	Share Diff	Share Chg %	Q2 2022 Value $	Q3 2022 Value $	Value Diff $	Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend

Quarterly Value Trend

Quarterly Shares Trend

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.